(duplicate) Bath Spondyloarthritis Biobank
Research type
Research Tissue Bank
IRAS ID
248375
Research summary
The Bath Spondyloarthritis (SpA) Biobank
REC name
South West - Central Bristol Research Ethics Committee
REC reference
18/SW/0141
Date of REC Opinion
6 Sep 2018
REC opinion
Further Information Favourable Opinion
Data collection arrangements
Demographic information (including GP details, ethnicity, age, education, employment, gender) \nClinical assessments (including symptoms, other diagnosis, x-rays, MRI, past medical history, medications, disease activity, symptom onset), family history, \nmetrology measurements, \nBlood samples (Serum / DNA / Plasma) \nPatient reported questionnaires (including pain, fatigue, work, comorbidity and quality of life and exercise) \nAdditional health risks (fractures and osteoporosis etc), and other relevant clinical information (including previous treatment). Informed consent will be taken in writing and stored in secure research facility and in patients’ notes.
Research programme
Patients with spondyloarthritis (an arthritis particularly affecting the spine, but may also have other manifestations) can develop profound symptoms that limit mobility and quality of life. Over time, some patients also develop changes to the bones of the spine, which can further restrict movement. We would like to better understand why some patients develop these features but others do not, and using blood biomarkers is a promising way of learning more about the disease process.
RTBTitle
The Bath Spondyloarthritis (SpA) Biobank
Establishment organisation
The Royal National Hospital for Rheumatic Diseases, Royal United Hospital NHS Foundation Trust
Establishment organisation address
Upper Borough Walls
Bath
BA1 1RL